Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis.
about
Potent Kinetic Stabilizers That Prevent Transthyretin-Mediated Cardiomyocyte ProteotoxicityAG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretinEvolving landscape in the management of transthyretin amyloidosisNovel drugs targeting transthyretin amyloidosis.Restrictive cardiomyopathy in inherited ATTR amyloidosis (TTR-Ser23Asn) in a patient of German-Italian extraction.Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs.Homozygosity for the E526V Mutation in Fibrinogen A Alpha-Chain Amyloidosis: The First ReportUpdates in cardiac amyloidosis: a review.Patient selection for cardiac transplant in 2012.Outcomes after heart transplantation for amyloid cardiomyopathy in the modern era.Emerging Advances in the Management of Cardiac Amyloidosis.Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.Heart transplantation in cardiac amyloidosis.Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective.Aged vervet monkeys developing transthyretin amyloidosis with the human disease-causing Ile122 allele: a valid pathological model of the human disease.The first Caucasian patient with p.Val122Ile mutated-transthyretin cardiac amyloidosis treated with isolated heart transplantationA compound T60A and V122I heterozygosity in the transthyretin gene causing early onset severe cardiac amyloidosisIsolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis
P2860
Q27671971-A8BB9303-E3CA-4A00-8858-F9178D50C39AQ27678369-AD140FC2-4E55-422D-98A7-B44482D445A4Q28086773-9AA5DE35-5BB8-49C7-A389-3E7A80EB7984Q34400138-0AAD4E11-6C0D-432D-95B9-A06F8A34848BQ34523243-C732CDA9-E839-4055-B4EB-3984A04CF48FQ35133371-C2AA7723-0893-45E3-B6BE-FDAD9C6FBDA4Q35823904-AE30F8D7-FEED-4D04-9414-F0E5C89C6461Q36366356-7A893066-B7A0-40AC-A2D5-2E741B6A657BQ38081154-662FBFBB-60D3-47BE-BDB0-8EDE025AC8E4Q38343098-F22DC954-6DCC-430B-82EE-280F127623F3Q38587648-8F2C9D5E-5106-4667-ACF1-9F556B29C78DQ39095033-888211E2-052F-4AD1-9B60-BD3DF463A2EFQ39172346-F06EAF8B-EADD-4F95-B1B7-3EEEAAEAFE53Q43598098-788CE4CA-7293-4576-A214-FABC74F03016Q45899656-2D566FBF-F25A-4394-9966-EC861AACF8FCQ58125111-889278FB-24F4-4FA2-B90A-9B9A75E443F7Q58190414-2BCA63F4-084D-4E42-9D3A-31815D8FC196Q58274881-DC220B93-F88A-409A-AE2E-65D083C9E10B
P2860
Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Heart transplantation for homo ...... TR) V122I cardiac amyloidosis.
@en
Heart transplantation for homozygous familial transthyretin
@nl
type
label
Heart transplantation for homo ...... TR) V122I cardiac amyloidosis.
@en
Heart transplantation for homozygous familial transthyretin
@nl
prefLabel
Heart transplantation for homo ...... TR) V122I cardiac amyloidosis.
@en
Heart transplantation for homozygous familial transthyretin
@nl
P2093
P2860
P1476
Heart transplantation for homo ...... TTR) V122I cardiac amyloidosis
@en
P2093
H J B Goodman
N R Banner
P N Hawkins
P2860
P304
P356
10.1111/J.1600-6143.2008.02162.X
P407
P577
2008-03-02T00:00:00Z